球囊阻塞術市場規模、佔有率和趨勢分析 |全球| 2026–2032年

2025年全球球囊阻塞市場規模約7,000萬美元。預計該市場將以3.5%的複合年成長率成長，到2032年達到約9,000萬美元。

本報告涵蓋全球球囊阻塞裝置市場，提供全面的市場分析，包括銷售量、平均售價（ASP）和市場規模。報告定量分析了各公司的銷售、市場規模、成長率和市場佔有率，涵蓋截至2022年的歷史數據以及截至2032年的預測數據。

球囊閉塞裝置在神經血管市場保持強大的競爭力，這主要得益於其相對於彈簧圈支架的顯著價格優勢，使其成為注重成本控制且擁有專業醫護人員的醫院的理想選擇。此外，技術進步已拓展了球囊導管的應用範圍，使其超越了傳統用途，近期研究證據支持其在藍圖攝影和血流導向裝置植入的應用。

該市場正面臨顯著的結構性阻力。自膨式神經血管支架的日益普及降低了對球囊擴張型的依賴，而ARUBA試驗後，液體栓塞劑在未破裂動靜脈畸形治療中的應用也減少了對球囊閉塞導管（其主要適應症之一）的需求。儘管球囊裝置具有價格競爭力，但這些趨勢仍在阻礙市場成長。

市場概覽

全球球囊阻斷市場是神經血管介入治療領域的細分市場。球囊阻斷導管用於在血管內手術過程中暫時阻斷血管內的血流，為栓塞、器械輸送和成像提供可控環境。它們與液體栓塞劑合併使用，以防止栓塞物質回流至動脈內；此外，它們也用於球囊輔助彈簧圈置入術，治療頸寬大的動脈瘤，為彈簧圈在動脈瘤囊內提供額外支撐。儘管市場規模較小，但它顯然滿足了神經血管治療工具包中的重要需求。

球囊栓塞裝置的主要商業性優勢在於其價格競爭力，且優於支架。對於對價格敏感且擁有訓練有素的醫護人員的醫院而言，球囊輔助栓塞術是更優的選擇，因為其單次手術的器械成本遠低於支架輔助栓塞術。球囊的平均售價約為同等栓塞適應症下支架的五分之一，預計這一成本差異將使注重成本的買家在整個預測期內對球囊裝置的需求保持穩定。

技術進步正在拓展球囊閉塞導管在手術中的應用範圍。除了在彈簧圈置入輔助和液體栓塞方面的既有作用外，近期研究表明，球囊藍圖導管還可作為母血管成像工具和血流導引裝置植入輔助工具。這些新應用拓寬了球囊裝置的應用場景，在一定程度上緩解了因市場結構性限制而導致的銷售量壓力。

兩大結構性不利因素正在限制市場成長上限。首先，神經血管支架市場正主要轉向自膨式支架設計，這種支架無需球囊導管即可展開，與球囊擴張型支架相比，血管損傷風險較低。其次，未破裂動靜脈畸形（AVM）治療方面臨床知識的進步正在降低液體栓塞劑的作用，因此，對需要合併使用球囊阻塞導管的介入治療的需求也在下降。

市場促進因素

價格優勢

球囊封堵器的平均售價約為栓塞術所用支架價格的五分之一，因此對於價格敏感且具備球囊輔助栓塞術操作能力的醫院而言，球囊封堵器是一個理想的選擇。這一顯著的成本優勢確保了球囊封堵器在神經血管市場上的競爭力，即使更先進的技術不斷出現。在預算管理至關重要的醫療環境中，對於某些類型的動脈瘤，球囊輔助栓塞術和支架輔助栓塞術的臨床療效差異尚不明確，此時球囊封堵術的成本效益就顯得尤為突出。預計這一價格趨勢將在整個預測期內維持穩定的需求基礎，尤其是在對成本更為敏感的新興市場。

技術進步

技術進步賦予了球囊閉塞裝置超越傳統手術用途的新應用，拓展了其臨床價值。 2022年的一項研究表明，球囊導管可用於對母血管進行藍圖成像，並輔助血流導向裝置的植入，顯著拓寬了其應用範圍。球囊導管設計的不斷改進，例如雙腔結構（允許透過單根導管同時進行球囊擴張和裝置輸送），也提高了手術效率，並促進了其在複雜病例中的應用。隨著涉及支架和血流導向裝置的手術數量不斷增加，球囊導管在這些情況下作為輔助工具的潛力正在催生更大的市場需求。

市場限制

自動擴張型支架的興起

目前，市面上大多數神經血管支架的設計都是自主擴張，而非透過球囊微導管植入。自動擴張型支架能夠緩慢擴張至所需的血管直徑，與早期臨床試驗中評估的球囊擴張型支架相比，其撕裂和破裂的風險較低。由於自動擴張型支架無需球囊即可植入，其廣泛應用正在減少支架輔助動脈瘤治療中對球囊閉塞導管的需求。這種轉變直接影響了球囊裝置歷來核心適應症之一的銷售，並構成了一種結構性阻力，預計將在整個預測期內持續存在。

液態栓塞劑減少

球囊阻塞導管用於液體栓塞術，以防止栓塞液回流至母動脈。因此，液體栓塞術的數量是球囊裝置需求的關鍵促進因素。 2020 年進行的 ARUBA 試驗的後續研究再次證實，與包括液體栓塞術在內的介入治療相比，藥物治療是治療未破裂動靜脈畸形 (AVM) 的更優選擇。這項發現導致未破裂 AVM 的液體栓塞術數量減少，進而導致與其合併使用的球囊阻塞導管的需求下降。由於臨床實踐中仍傾向於採用保守治療未破裂 AVM，這仍然是球囊阻塞導管市場成長的重大結構性阻礙因素。

目錄

調查方法

• 第一步：專案推出與團隊組建
• 步驟二：資料系統開發與二次調查實施
• 步驟三：準備面試設計問卷
• 第四步：進行初步調查
• 第五步：調查分析：基準估計
• 第六步：市場預測與分析
• 第七步：辨識策略機遇
• 步驟 8：最終確認和市場公告
• 步驟九：客戶回饋與市場監測

全球關稅的影響

球囊阻塞市場

• 執行摘要
  • 全球球囊阻塞市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
• 市場分析與預測
• 促進因素和抑制因素
  • 市場促進因素
  • 市場限制因素
• 競爭對手市佔率分析

附錄

The global balloon occlusion market was valued at approximately $70 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.5%, reaching approximately $90 million by 2032.

This report covers the global market for balloon occlusion devices and includes complete market analyses of unit sales, average selling prices (ASPs), and market values. The report quantifies units sold, market size, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.

Balloon occlusion devices maintain a competitive position in the neurovascular market through a significant price advantage over stents for coiling procedures, making them the preferred option for cost-sensitive hospitals with capable staff. Technological advancements are also expanding the application range of balloon catheters beyond traditional uses, with recent evidence supporting their role in road-map imaging and flow-diverter placement.

The market faces meaningful structural headwinds. The widespread adoption of self-expanding neurovascular stents is reducing reliance on balloon-expandable alternatives, while declining use of liquid embolics for unruptured AVMs following the ARUBA trial findings has reduced demand for balloon occlusion catheters in one of their core procedural applications. These dynamics constrain growth despite the price-competitive positioning of balloon devices.

Market Overview

The global balloon occlusion market is a specialized segment within the broader neurovascular intervention space. Balloon occlusion catheters are used to temporarily block blood flow within a vessel during endovascular procedures, providing a controlled environment for embolization, device delivery, and imaging. They are used alongside liquid embolics to limit reflux of embolic material back into the artery, as well as in balloon-assisted coiling for wide-necked aneurysms where additional support is required to keep coils within the aneurysm sac. The market is small but serves a distinct procedural need within the neurovascular toolkit.

The primary commercial advantage of balloon occlusion devices is their price position relative to stents. For price-sensitive hospitals with appropriately trained staff, a balloon-assisted coiling approach is the preferred option due to the significantly lower per-procedure device cost compared to stent-assisted coiling. This cost differential, with balloon ASPs approximately five times lower than those of stents for comparable coiling indications, is expected to sustain demand for balloon devices among cost-conscious buyers throughout the forecast period.

Technological advancement is expanding the procedural versatility of balloon occlusion catheters. In addition to their established roles in coiling assistance and liquid embolic delivery, recent evidence has demonstrated that balloon catheters can be used as a tool to enable road-map imaging of parent vessels and to assist with flow-diverter placement. These emerging applications broaden the use cases for balloon devices and partially offset the volume pressure from structural market limiters.

Two structural headwinds are shaping the market's growth ceiling. First, the neurovascular stent market has moved predominantly toward self-expanding designs, which do not require balloon catheters for deployment and carry lower vessel trauma risk compared to balloon-expandable alternatives. Second, evolving clinical evidence on the management of unruptured arteriovenous malformations has reduced the role of liquid embolics, which in turn reduces the procedural demand for balloon occlusion catheters that are used alongside them.

Market Drivers

Incentive Pricing

The ASP of balloon occlusion devices is approximately five times lower than the price of stents for coiling procedures, making them the preferred option for price-sensitive hospitals with the staff capability to perform balloon-assisted coiling. This substantial cost advantage allows balloon devices to remain competitive in the neurovascular market even as more advanced technologies become available. In healthcare environments where budget management is a priority and where the clinical outcome difference between balloon-assisted and stent-assisted coiling is not definitive for certain aneurysm types, the cost case for balloon occlusion is straightforward. This pricing dynamic is expected to sustain a reliable base of demand throughout the forecast period, particularly in emerging markets where cost sensitivity is more pronounced.

Technological Advancement

Technological advancements are enabling novel uses for balloon occlusion devices that extend their clinical value beyond traditional procedural roles. A 2022 study demonstrated that balloon catheters can be used as a method to enable road-map imaging of parent vessels and to assist with flow-diverter placement, representing a meaningful expansion of their application. Ongoing improvements to balloon catheter design, including dual-lumen configurations that allow simultaneous balloon inflation and device delivery through a single catheter, are also making procedures more efficient and supporting adoption in complex cases. As stent and flow-diverter procedures grow in volume, the potential for balloon catheters to serve as adjunctive tools in these settings adds incremental demand to the market.

Market Limiters

Rise of Self-Expandable Stents

The majority of neurovascular stents on the market are now designed to be self-expanding rather than deployed via a balloon microcatheter. Self-expanding stents gently open to the desired vessel diameter and carry a lower risk of dissection or vessel rupture compared to balloon-expandable stents that were evaluated in earlier clinical trials. Because self-expanding stents do not require a balloon for deployment, their widespread adoption has reduced the procedural need for balloon occlusion catheters in stent-assisted aneurysm treatment. This shift has directly constrained unit sales for balloon devices in one of their historically core indications and represents a structural headwind that is expected to persist over the forecast period.

Decline of Liquid Embolics

Balloon occlusion catheters are used in liquid embolic procedures to limit the reflux of embolic fluid back into the parent artery, making the volume of liquid embolic procedures a key demand driver for balloon devices. A 2020 follow-up to the ARUBA trial re-concluded that medication was a superior treatment method for unruptured arteriovenous malformations compared to interventional approaches including liquid embolization. This finding has contributed to a reduction in liquid embolic procedure volumes for unruptured AVMs, which in turn reduces demand for the balloon occlusion catheters used alongside them. As the clinical preference for conservative management of unruptured AVMs continues, this remains a meaningful structural limiter on balloon occlusion market growth.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and technology trends shaping demand.
• Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
• Data sources: Primary interviews with neurovascular device industry leaders and neurointerventional physicians, regulatory data, hospital procurement data, import and export data, and the iData Research internal database.
• Care settings: Hospitals and neurovascular intervention centers.

Markets Covered and Segmentation

• The balloon occlusion market is analyzed as a unified segment, assessed by unit volume, ASP, and market value with historical and forecast data provided:
• Balloon Occlusion Devices

Competitive Analysis

Terumo led the balloon occlusion device market in 2025 through its Scepter C and Scepter XC dual-lumen occlusion balloon catheters. These devices are designed for versatile use across stent delivery, liquid embolic procedures, and balloon occlusion applications. The dual-lumen design allows physicians to simultaneously inflate the balloon and deliver a device or agent through the same catheter, improving procedural efficiency in complex cases. Terumo's strength in the guiding catheter segment of the broader neurovascular market also supports its commercial relationships and distribution access in this adjacent balloon catheter category.

Stryker was the second-leading competitor in the balloon occlusion device market in 2025. The company offers the Transform and Transform Super Occlusion Balloon catheters, which are single-lumen devices designed to control blood flow and support embolization procedures. Key product features include hydrophilic coating to reduce friction during navigation and radiopaque markers that improve visibility under fluoroscopy, supporting precise catheter positioning during procedures. Stryker's established presence across the broader neurovascular intervention market supports its distribution and clinical relationships in the balloon occlusion segment.

Medtronic was the third-leading competitor in the balloon occlusion device market in 2025. The company offers the HyperForm and HyperGlide occlusion balloon systems, originally developed through the Covidien acquisition. These devices are known for their adaptability to complex vessel anatomy and their ability to access distal vasculature, supporting use in anatomically demanding cases. Medtronic's combined neurovascular portfolio, which spans catheters, guidewires, and embolization platforms, allows it to position balloon occlusion products as part of a broader procedural offering.

Technology and Practice Trends

• Dual-lumen catheter design: Dual-lumen balloon configurations allow simultaneous balloon inflation and device or agent delivery through a single catheter, improving efficiency and reducing the number of exchanges required in complex procedures.
• Road-map imaging applications: Clinical evidence published in 2022 supports the use of balloon catheters for road-map imaging of parent vessels, expanding their role in procedures beyond coiling and embolization.
• Flow-diverter placement support: Balloon catheters are demonstrating utility in assisting flow-diverter deployment, adding a newer adjunctive application that creates incremental demand as flow-diverter procedure volumes grow.
• Hydrophilic coatings and radiopaque markers: Improvements to surface coatings and fluoroscopic visibility features are improving navigational performance and reducing friction-related complications during catheter delivery.
• Self-expanding stent displacement: The shift toward self-expanding neurovascular stents is reducing balloon catheter use in stent-assisted procedures, reshaping where balloon devices remain most clinically relevant.
• AVM management evolution: Changing clinical guidance on unruptured AVM treatment is reducing liquid embolic procedural volumes, which directly affects balloon occlusion catheter demand in that indication.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• Where are the remaining growth opportunities within the global balloon occlusion market as self-expanding stents and declining liquid embolic volumes constrain traditional demand through 2032?
• How does the price advantage of balloon occlusion devices over stents for coiling support their commercial position in cost-sensitive hospital environments?
• What emerging procedural applications, including road-map imaging and flow-diverter placement assistance, are expanding the clinical role of balloon catheters?
• How are dual-lumen versus single-lumen catheter designs differentiated in terms of procedural utility and market positioning?
• Which companies lead the market and how do their product platforms address different procedural requirements in balloon-assisted neurovascular intervention?
• What is the outlook for balloon occlusion demand in liquid embolic procedures following the ARUBA trial findings on unruptured AVM management?
• How is the shift toward self-expanding stents reshaping the procedural settings where balloon occlusion catheters remain most clinically relevant?
• What are the key risks to growth, including structural volume headwinds from stent technology evolution and changing AVM treatment guidelines?

The Global Balloon Occlusion Market Report from iData Research answers these questions with unit-level models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, and plan commercial strategy across a niche market defined by a strong price position and narrowing but evolving procedural applications.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Balloon Occlusion Market

• 10.1 Executive Summary
  • 10.1.1 Global Balloon Occlusion Market Overview
  • 10.1.2 Competitive Analysis
  • 10.1.3 Markets Included
  • 10.1.4 Regions Included
• 10.2 Introduction
• 10.3 Market Analysis And Forecast
• 10.4 Drivers And Limiters
  • 10.4.1 Market Drivers
  • 10.4.2 Market Limiters
• 10.5 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

• Chart 10-1: Balloon Occlusion Market, Global, 2025 & 2032
• Chart 10-2: Balloon Occlusion Units, Global, 2025
• Chart 10-3: Balloon Occlusion Market, Global, 2022 - 2032
• Chart 10-4: Leading Competitors, Balloon Occlusion Market, Global, 2025

LIST OF FIGURES

• Figure 10-1: Balloon Occlusion Markets Covered
• Figure 10-2: Balloon Occlusion Regions Covered, Global (1 of 2)
• Figure 10-3: Balloon Occlusion Regions Covered, Global (2 of 2)
• Figure 10-4: Balloon Occlusion Market, Global, 2022 - 2032
• Figure 10-5: Units Sold by Region, Balloon Occlusion Market, Global, 2022 - 2032
• Figure 10-6: Average Selling Price by Region, Balloon Occlusion Market, Global, 2022 - 2032 (US$)
• Figure 10-7: Market Value by Region, Balloon Occlusion Market, Global, 2022 - 2032 (US$M)
• Figure 10-8: Leading Competitors, Balloon Occlusion Market, Global, 2025